San Francisco, CA, United States of America

Steven T Staben

This inventor holds 38 USPTO granted patents and 15 published patent applications, plus 3 CIPO patents and 16 EPO patents, primarily in PI3K Inhibitors. Top assignees: Genentech, Inc., F. Hoffmann-La Roche Ag, Hoffmann-La Roche Inc.. Active years: 2011-2026.

USPTO Granted Patents = 38 (Patent Applications = 15)

% Patents Active = 92.1

CIPO Patents = 3

EPO Patents = 16 (Patent Applications = 22)

Average Co-Inventor Count = 9.1

ph-index = 9

Forward Citations = 278(Granted Patents)

Location History:

San Francisco, CA (US) (2013 - 2023)
South San Francisco, CA (US) (2011 - 2024)

Company Filing History:

F. Hoffmann-La Roche Ag

patents

2 out of 5,016

Hoffmann-La Roche Inc.

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

PI3K Inhibitors

Sulfonimidamide Compounds

Benzoxazepin Compounds

Therapeutic Compounds

Tricyclic Compounds

Interleukin-1 Activity

Cancer Treatment

Bromodomain Inhibitors

PROTAC Antibody Conjugates

Heterocyclic Compounds

Phosphoinositide 3-Kinase

Benzopyran Compounds

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12617802 - Sulfonimidamide compounds as NLRP3 modulators (2026-05-05),

2. 12234245 - Sulfonimidamide compounds as inhibitors of interleukin-1 activity (2025-02-25),

3. 12152040 - Tert-butyl (s)-2-(4-(phenyl)-6H-thieno[3, 2-f][1, 2, 4]triazolo[4, 3-a] [1,4]diazepin-6-yl) acetate derivatives and related compounds as bromodomain BRD4 inhibitors for treating cancer (2024-11-26),

4. 12006331 - Therapeutic compounds and methods (2024-06-11),

5. 11760753 - Benzoxazepin oxazolidinone compounds and methods of use (2023-09-19),

6. 11666581 - PROTAC antibody conjugates and methods of use (2023-06-06),

7. 11560391 - Sulfonylurea compounds as inhibitors of interleukin-1 activity (2023-01-24),

8. 11242344 - (4-hydroxypyrrolidin-2-yl)-heterocyclic compounds and methods of use thereof (2022-02-08),

9. 10851091 - Benzoxazepin oxazolidinone compounds and methods of use (2020-12-01),

10. 10435414 - Tricyclic PI3K inhibitor compounds and methods of use (2019-10-08),

11. 10112932 - Benzoxazepin oxazolidinone compounds and methods of use (2018-10-30),

12. 10065970 - Tricyclic PI3K inhibitor compounds and methods of use (2018-09-04),

13. 9670228 - Benzoxazepin PI3K inhibitor compounds and methods of use (2017-06-06),

14. 9650393 - Benzoxazepin oxazolidinone compounds and methods of use (2017-05-16),

15. 9643980 - Benzoxazepin oxazolidinone compounds and methods of use (2017-05-09),

Title: Steven T Staben - Pioneering Inventor from San Francisco

Introduction: Steven T Staben is a renowned inventor based in San Francisco, CA, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Steven T Staben holds several patents in the areas of technology, healthcare, and sustainability, showcasing his diverse range of expertise and interests.

Career Highlights: With a career spanning over two decades, Steven T Staben has consistently pushed the boundaries of innovation, with his inventions revolutionizing industries and improving the lives of many.

Collaborations: Throughout his career, Steven T Staben has collaborated with leading companies, research institutions, and universities to further develop and implement his inventions, solidifying his reputation as a visionary inventor.

Conclusion: Steven T Staben's passion for innovation and his relentless drive to create have established him as a prominent figure in the world of inventors, with his work leaving a lasting impact on society.